282 related articles for article (PubMed ID: 31111624)
1. Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice.
Zhou Y; Han D; Follansbee T; Wu X; Yu S; Wang B; Shi Z; Domocos DT; Carstens M; Carstens E; Hwang ST
J Cell Mol Med; 2019 Jul; 23(7):4819-4828. PubMed ID: 31111624
[TBL] [Abstract][Full Text] [Related]
2. TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
Zhou Y; Follansbee T; Wu X; Han D; Yu S; Domocos DT; Shi Z; Carstens M; Carstens E; Hwang ST
J Dermatol Sci; 2018 Dec; 92(3):264-271. PubMed ID: 30527377
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-18 exacerbates skin inflammation and affects microabscesses and scale formation in a mouse model of imiquimod-induced psoriasis.
Niu XL; Huang Y; Gao YL; Sun YZ; Han Y; Chen HD; Gao XH; Qi RQ
Chin Med J (Engl); 2019 Mar; 132(6):690-698. PubMed ID: 30741833
[TBL] [Abstract][Full Text] [Related]
4. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
5. Effects of Topical Application of Betamethasone on Imiquimod-induced Psoriasis-like Skin Inflammation in Mice.
Mori H; Arita K; Yamaguchi T; Hirai M; Kurebayashi Y
Kobe J Med Sci; 2016 Sep; 62(4):E79-E88. PubMed ID: 28239073
[TBL] [Abstract][Full Text] [Related]
6. TRPA1 Acts in a Protective Manner in Imiquimod-Induced Psoriasiform Dermatitis in Mice.
Kemény Á; Kodji X; Horváth S; Komlódi R; Szőke É; Sándor Z; Perkecz A; Gyömörei C; Sétáló G; Kelemen B; Bíró T; Tóth BI; Brain SD; Pintér E; Gyulai R
J Invest Dermatol; 2018 Aug; 138(8):1774-1784. PubMed ID: 29550417
[TBL] [Abstract][Full Text] [Related]
7. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
[TBL] [Abstract][Full Text] [Related]
8. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
[TBL] [Abstract][Full Text] [Related]
9. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin.
Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413
[TBL] [Abstract][Full Text] [Related]
10.
Fujii K; Yamamoto Y; Mizutani Y; Saito K; Seishima M
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752186
[No Abstract] [Full Text] [Related]
11. IL-1R1 signaling facilitates Munro's microabscess formation in psoriasiform imiquimod-induced skin inflammation.
Uribe-Herranz M; Lian LH; Hooper KM; Milora KA; Jensen LE
J Invest Dermatol; 2013 Jun; 133(6):1541-9. PubMed ID: 23407395
[TBL] [Abstract][Full Text] [Related]
12. Fucosylation deficiency enhances imiquimod-induced psoriasis-like skin inflammation by promoting CXCL1 expression.
Li N; Lee Y; Suh JH; Oh JH; Jin SP; Lee DH; Chung JH
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166988. PubMed ID: 38070583
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of IL-17-committed T cells in a murine psoriasis model by a vitamin D analogue.
Kusuba N; Kitoh A; Dainichi T; Honda T; Otsuka A; Egawa G; Nakajima S; Miyachi Y; Kabashima K
J Allergy Clin Immunol; 2018 Mar; 141(3):972-981.e10. PubMed ID: 28870465
[TBL] [Abstract][Full Text] [Related]
14. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
[TBL] [Abstract][Full Text] [Related]
15. Glycerol Improves Skin Lesion Development in the Imiquimod Mouse Model of Psoriasis: Experimental Confirmation of Anecdotal Reports from Patients with Psoriasis.
Choudhary V; Kaddour-Djebbar I; Custer VE; Uaratanawong R; Chen X; Cohen E; Yang R; Ajebo E; Hossack S; Bollag WB
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445455
[TBL] [Abstract][Full Text] [Related]
16. Topical Application of BMS-509744, a Selective Inhibitor of Interleukin-2-Inducible T Cell Kinase, Ameliorates Imiquimod-Induced Skin Inflammation in Mice.
Otake S; Otsubaki T; Uesato N; Ueda Y; Murayama T; Hayashi M
Biol Pharm Bull; 2021 Apr; 44(4):528-534. PubMed ID: 33473072
[TBL] [Abstract][Full Text] [Related]
17. Topical application of endothelin receptor a antagonist attenuates imiquimod-induced psoriasiform skin inflammation.
Nakahara T; Kido-Nakahara M; Ulzii D; Miake S; Fujishima K; Sakai S; Chiba T; Tsuji G; Furue M
Sci Rep; 2020 Jun; 10(1):9510. PubMed ID: 32528072
[TBL] [Abstract][Full Text] [Related]
18. TLR2 Deficiency Exacerbates Imiquimod-Induced Psoriasis-Like Skin Inflammation through Decrease in Regulatory T Cells and Impaired IL-10 Production.
Nakao M; Sugaya M; Fujita H; Miyagaki T; Morimura S; Shibata S; Asano Y; Sato S
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202847
[TBL] [Abstract][Full Text] [Related]
19. Stress aggravates and prolongs imiquimod-induced psoriasis-like epidermal hyperplasis and IL-1β/IL-23p40 production.
Wang Y; Li P; Zhang L; Fu J; Di T; Li N; Meng Y; Guo J; Zhao J
J Leukoc Biol; 2020 Jul; 108(1):267-281. PubMed ID: 32421901
[TBL] [Abstract][Full Text] [Related]
20. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages.
Morimura S; Oka T; Sugaya M; Sato S
J Dermatol Sci; 2016 Jun; 82(3):175-88. PubMed ID: 26976687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
